Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

2009 ◽  
Vol 135 (9) ◽  
pp. 1169-1175 ◽  
Author(s):  
Ioannis Zachos ◽  
Panagiotis A. Konstantinopoulos ◽  
Gerasimos P. Vandoros ◽  
Michalis V. Karamouzis ◽  
Athanasios G. Papatsoris ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
Reverse Transcriptase ◽  
Predictive Value ◽  
Superficial Bladder Cancer ◽  
Telomerase Reverse Transcriptase ◽  
Bcg Immunotherapy

756: Neutrophil Granulocytes are Essential During BCG Immunotherapy of Superficial Bladder Cancer

2005 ◽  
Vol 173 (4S) ◽  
pp. 205-205
Author(s):  
Henrik Suttmann ◽  
Josef Riemensberger ◽  
Andreas Böhle ◽  
Dieter Jocham ◽  
Sven Brandau
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Neutrophil Granulocytes ◽  
Bcg Immunotherapy

scholarly journals The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer

Bioengineered ◽  
2021 ◽  
Vol 12 (1) ◽  
pp. 1495-1504
Author(s):  
Song Wan ◽  
Xuan Liu ◽  
Wei Hua ◽  
Ming Xi ◽  
Yulin Zhou ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Reverse Transcriptase ◽  
Telomerase Reverse Transcriptase ◽  
Tert Promoter ◽  
Tert Promoter Mutations ◽  
Promoter Mutations
Sign in / Sign up

Export Citation Format

Share Document